Implications of the FDA approval of PCSK9 inhibitors and FOURIER results for contemporary cardiovascular practice: An NCDR Research to Practice (R2P) project

Implications of the FDA approval of PCSK9 inhibitors and FOURIER results for contemporary cardiovascular practice: An NCDR Research to Practice (R2P) project

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: American Heart Journal - Volume 195, January 2018, Pages 151-152

Paul L. MD, MHS, Kevin MS, Michael MD, Salim S. MD, PhD, Frederick A. MD, MSPH, Ann Marie MD, PhD, Robert W. MD, MSc, P. Michael MD, PhD, Thomas M. MD, MSc,